Acylated Iridoids from the Roots of Valeriana Officinalis Var. Latifolia
Zhu-zhen Han,Zhao-hui Yan,Qing-xin Liu,Xian-qing Hu,Ji Ye,Hui-liang Li,Wei-dong Zhang
DOI: https://doi.org/10.1055/s-0032-1315214
IF: 3.007
2012-01-01
Planta Medica
Abstract:Phytochemical investigation of the roots of Valeriana officinalis var. latifolia resulted in the isolation and characterization of six new acylated iridoids, (5S,7S,8S,9S)-7-hydroxy-8-isovaleroyloxy Delta(4,11)-dihyronepetalactone (1),(5S,7S,8S,9S)-7-hydroxy-10-isovaleroyloxy-Delta(4,11)-dihyronepetalactone (2),(5S,8S,9S)-10-isovaleroyloxy-Delta(4,11)-dihyronepetalactone (3), (5S, 6S, 8S, 9R)-6-isovaleroyloxy-Delta(4,11)-1,3-diol (4), (5S, 6S, 8S, 9R)-1,3-isovaleroxy-Delta(4,11)-1,3-diol (5), and (5S, 6S, 8S, 9R)-3-isovaleroxy- 6-isovaleroyloxy-Delta(4,11)-1,3-diol (6). Their structures were determined mainly by 1D and 2D NMR spectroscopic techniques. We also report herein for the first time the single crystal X-ray structure of compound 1. In addition, the cytotoxic activities of compounds 1-6 were evaluated against A549 (human lung adenocarcinoma), HCT116 (human colon carcinoma), SK-BR-3 (human breast carcinoma), and HepG2 (human hepatoma) cell lines. Compound 6 showed weak cell growth inhibition of A549, HCT116, SK-BR-3, and HepG2 cells.